Home
>
National Drug Code (NDC)
>
Orphenadrine Citrate
Orphenadrine Citrate - 25021-651-02 - (orphenadrine citrate)
Drug Information of Orphenadrine Citrate
| Product NDC: | 25021-651 |
| Proprietary Name: | Orphenadrine Citrate |
| Non Proprietary Name: | orphenadrine citrate |
| Active Ingredient(s): | 30 mg/mL & nbsp; orphenadrine citrate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Orphenadrine Citrate
| Product NDC: | 25021-651 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090585 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111001 |
Package Information of Orphenadrine Citrate
| Package NDC: | 25021-651-02 |
| Package Description: | 10 VIAL in 1 CARTON (25021-651-02) > 2 mL in 1 VIAL |
NDC Information of Orphenadrine Citrate
| NDC Code | 25021-651-02 |
| Proprietary Name | Orphenadrine Citrate |
| Package Description | 10 VIAL in 1 CARTON (25021-651-02) > 2 mL in 1 VIAL |
| Product NDC | 25021-651 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | orphenadrine citrate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20111001 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | ORPHENADRINE CITRATE |
| Strength Number | 30 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |
